title: Game theory in the death galaxy: interaction of cancer and stromal cells in tumour microenvironment.
abstract: Preventing relapse is the major challenge to effective therapy in cancer. Within the tumour, stromal (ST) cells play an important role in cancer progression and the emergence of drug resistance. During cancer treatment, the fitness of cancer cells can be enhanced by ST cells because their molecular signalling interaction delays the drug-induced apoptosis of cancer cells. On the other hand, competition among cancer and ST cells for space or resources should not be ignored. We explore the population dynamics of multiple myeloma (MM) versus bone marrow ST cells by using an experimental microecology that we call the death galaxy, with a stable drug gradient and connected microhabitats. Evolutionary game theory is a quantitative way to capture the frequency-dependent nature of interactive populations. Therefore, we use evolutionary game theory to model the populations in the death galaxy with the gradients of pay-offs and successfully predict the future densities of MM and ST cells. We discuss the possible clinical use of such analysis for predicting cancer progression.
authors.affiliation: Princeton Institute for the Science and Technology of Materials (PRISM) , Princeton, NJ 08544 , USA ; Department of Electrical Engineering , Princeton University , Princeton, NJ 08544 , USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Wu
authors.affiliation: Department of Pathology , University of California at San Francisco , CA 94143 , USA.
authors.forename: David
authors.initials: D
authors.lastname: Liao
authors.affiliation: Department of Pathology , University of California at San Francisco , CA 94143 , USA.
authors.forename: Thea D
authors.initials: TD
authors.lastname: Tlsty
authors.affiliation: Princeton Institute for the Science and Technology of Materials (PRISM) , Princeton, NJ 08544 , USA ; Department of Electrical Engineering , Princeton University , Princeton, NJ 08544 , USA.
authors.forename: James C
authors.initials: JC
authors.lastname: Sturm
authors.affiliation: Princeton Institute for the Science and Technology of Materials (PRISM) , Princeton, NJ 08544 , USA ; Department of Physics , Princeton University , Princeton, NJ 08544 , USA.
authors.forename: Robert H
authors.initials: RH
authors.lastname: Austin
keywords: cancer; chemotherapy resistance; game theory; population dynamics; spatial heterogeneity; stroma
references.citation: J Bacteriol. 2007 Mar;189(5):1756-64
references.pmid: 17189361
references.citation: Mol Pharm. 2011 Dec 5;8(6):2039-49
references.pmid: 22067046
references.citation: Science. 2011 Sep 23;333(6050):1764-7
references.pmid: 21940899
references.citation: Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16103-8
references.pmid: 24046372
references.citation: Pharmacol Rev. 2004 Jun;56(2):185-229
references.pmid: 15169927
references.citation: Nature. 2012 Jul 26;487(7408):505-9
references.pmid: 22763448
references.citation: Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8782-8
references.pmid: 16361566
references.citation: Cancer Discov. 2013 Jun;3(6):658-73
references.pmid: 23729478
references.citation: Annu Rev Pathol. 2006;1:119-50
references.pmid: 18039110
references.citation: Br J Cancer. 2009 Oct 6;101(7):1130-6
references.pmid: 19724279
references.citation: Semin Cell Dev Biol. 2010 Feb;21(1):11-8
references.pmid: 19857593
references.citation: Nat Rev Cancer. 2011 May;11(5):375-82
references.pmid: 21508974
references.citation: Nat Med. 2010 Apr;16(4):483-9
references.pmid: 20228816
references.citation: Nat Med. 2012 Sep;18(9):1359-68
references.pmid: 22863786
references.citation: J Natl Compr Canc Netw. 2009 Oct;7(9):908-42
references.pmid: 19878637
references.citation: Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6853-6
references.pmid: 21474778
references.citation: Evolution. 2007 Oct;61(10):2281-92
references.pmid: 17711471
references.citation: Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10334-9
references.pmid: 22689955
references.citation: Interface Focus. 2014 Aug 6;4(4):20140038
references.pmid: 25097752
references.citation: Nat Rev Mol Cell Biol. 2009 Mar;10(3):218-27
references.pmid: 19234479
references.citation: Cancer Res. 2009 Nov 15;69(22):8797-806
references.pmid: 19887618
references.citation: Annu Rev Biophys Biomol Struct. 2007;36:213-31
references.pmid: 17269901
references.citation: Phys Biol. 2011 Feb;8(1):015016
references.pmid: 21301070
references.citation: J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54
references.pmid: 17895480
references.citation: Blood. 2004 May 1;103(9):3503-10
references.pmid: 14670925
references.citation: Clin Cancer Res. 2008 May 1;14(9):2519-26
references.pmid: 18451212
references.citation: Nat Rev Cancer. 2009 Sep;9(9):665-74
references.pmid: 19693095
references.citation: Nat Rev Cancer. 2013 Dec;13(12):883-92
references.pmid: 24213474
references.citation: Mol Pharm. 2011 Dec 5;8(6):2063-8
references.pmid: 22085251
references.citation: Interface Focus. 2014 Aug 6;4(4):20140037
references.pmid: 25097751
references.citation: Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1686-91
references.pmid: 23319630